KENYA – The Masinde Muliro University of Science and Technology (MMUST) and the Immunify.Life, a transformative blockchain-based healthcare ecosystem, have formally launched a blockchain-based HIV/AIDS treatment outcomes study in Kenya.
The HIV/AIDS treatment outcomes study is an elegant application of the Immunify.Life technology, and the results from the study will contribute to the future strategic direction of HIV treatment in the country.
The new study aims to leverage the healthcare ecosystem’s cutting-edge new frontier technology designed to address the challenges of HIV and AIDS, tuberculosis, and vaccination programmes.
It could boost HIV prevention efforts in Kenya and beyond since the country has one of the world’s largest populations of people living with HIV/AIDs and approximately 30% are not taking treatment.
In addition, the project has critical components such as HIV and AIDS screening, laboratory tests, treatment, follow-up care, peer group support, tracking of treatment outcomes, tracking of retention on treatment, and enhanced paperless data.
Immunify.Life announced in a statement that the company worked closely with the Masinde Muliro University to complete the groundwork to scale up the HIV/AIDS treatment outcomes study before the formal launch.
“As part of the study, the Immunify.Life data capture and processing platform will be used to help empower patients, communities, and entire countries using token rewards that can improve medical regimen adherence rates in previously lapsed HIV/AIDS patients,” the company said.
It is a complete and fully-sustainable platform that can be used to incentivize patients, run health campaigns, and seamlessly integrate peripheral health-related data and data management tools for providers, patients, families, and more.
Immunify.Life CEO Guy Newing reaffirmed that blockchain technology is the cutting-edge new frontier technology that will revolutionize healthcare in Africa.
“By collaborating with relevant government health ministries and subsidiary entities, NGOs, partner health organizations, for-profit partners, donors, and more, Immunify.Life is in the business of unlocking the latent power and benefits of innovative technology in the healthcare space,” the statement said.
Dr. Mutay, the Head of the Medical School at MMUST, said the university’s Vice Chancellor is keen on strengthening research capacity and has championed the setting up of research teams to write proposals in different areas.
He further said that the project will receive the required administrative support while noting that they expect that the project can be used to touch lives and solve the problems of the community.
Project Coordinator of the Immunify.Life MMUST Dr. Tecla Jerotich Sum reaffirmed that the organization’s teams are committed to improving the health outcomes and wellness of all people affected and infected with HIV and AIDS.
“We are using science, innovation, technology, and compassion to improve quality of care and avoid loss in the cascade of care,” she said.
Dr. Sum continued to describe the benefits of the system by expressing her excitement about this project because its success will spread to the whole country and later to the whole continent.
Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE
